June 27, 2016
Mayo Clinic Introduces Precision Medicine in Psychiatry
By Jeff Briggs
The right drug at the right dose at the right time. Faithful readers of the Center for Individualized Medicine blog already know we’re talking again about pharmacogenomics, or PGx. As we’ve explored in previous posts, these “right” goals drive pharmacogenomics — how genetics influence a person’s response to medications. But can pharmacogenomics and precision medicine […]
Tags: antidepressants, center for individualized medicine, CYP2D6, depression, Dr. Mark Frye, Dr. Wayne Nicholson, genome, mental health, pharmacogenomics, Precision Medicine, Prozac, Psychiatry
December 23, 2014
Don’t Change Breast Cancer Guidelines on Flawed Research
By Center for Individualized Medicine
Clinical recommendations discouraging the use of CYP2D6 gene testing to guide tamoxifen therapy in breast cancer patients are based on studies with flawed methodology and should be reconsidered, according to the results of a Mayo Clinic study published in the Journal of the National Cancer Institute. For years, controversy has surrounded the CYP2D6 […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, CYP2D6, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, genome science, Genome Sequencing